GoAI
Get started
BrightSpring Health Services, Inc. Common Stock logo

BrightSpring Health Services, Inc. Common Stock

BTSG

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$58.87

−$0.66 · -1.11%

Aug 21, 4:00 PM ET

BTSG company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

60

Fair Value

Momentum

68

Gaining

Sentiment

58

Mixed

Risk resilience

69

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Jon Rousseau
Listed since
Jan 26, 2024
Employees
23,500

Market position

Day range

Current $58.87

52-week range

Current $58.87

Open
$59.75
Previous close
$59.53
Volume
1.52M
0.44× average
Average volume
3.48M
Average daily volume
Market cap
11.55B USD
Beta
1.88
Market reference 1
50-day average
$66.2721
-11.17% below average
200-day average
$48.7618
+20.73% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
10.2B USD
EV / EBITDA
22.21×
Earnings yield
2.51%
Free cash flow yield
5.20%

Profitability & efficiency

Return on equity
10.17%
Return on assets
2.97%
Return on invested capital
4.81%

Financial health

Current ratio
1.57×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends21%13%4%-4%Gross margin, FY2021: 18.64%Gross margin, FY2022: 17.54%Gross margin, FY2023: 16.24%Gross margin, FY2024: 14.10%Gross margin, FY2025: 11.76%Operating margin, FY2021: 3.50%Operating margin, FY2022: 2.43%Operating margin, FY2023: 1.67%Operating margin, FY2024: 1.83%Operating margin, FY2025: 2.29%Net margin, FY2021: 0.74%Net margin, FY2022: -0.70%Net margin, FY2023: -1.75%Net margin, FY2024: -0.16%Net margin, FY2025: 1.48%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 18.64%. Gross margin FY2022 17.54%. Gross margin FY2023 16.24%. Gross margin FY2024 14.10%. Gross margin FY2025 11.76%. Operating margin FY2021 3.50%. Operating margin FY2022 2.43%. Operating margin FY2023 1.67%. Operating margin FY2024 1.83%. Operating margin FY2025 2.29%. Net margin FY2021 0.74%. Net margin FY2022 -0.70%. Net margin FY2023 -1.75%. Net margin FY2024 -0.16%. Net margin FY2025 1.48%.

Income trends

Revenue

12.91B USD+14.59%

Operating income

295.25M USD+43.07%

Net income

190.67M USD+208.73M USD
Income trends across reported periods14.22B USD8.99B USD3.76B USD−1.46B USDRevenue, FY2021: 6.7B USDRevenue, FY2022: 7.72B USDRevenue, FY2023: 8.83B USDRevenue, FY2024: 11.27B USDRevenue, FY2025: 12.91B USDOperating income, FY2021: 234.18M USDOperating income, FY2022: 187.83M USDOperating income, FY2023: 147.18M USDOperating income, FY2024: 206.37M USDOperating income, FY2025: 295.25M USDNet income, FY2021: 49.8M USDNet income, FY2022: −53.91M USDNet income, FY2023: −154.6M USDNet income, FY2024: −18.06M USDNet income, FY2025: 190.67M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 6.7B USD. Revenue FY2022 7.72B USD. Revenue FY2023 8.83B USD. Revenue FY2024 11.27B USD. Revenue FY2025 12.91B USD. Operating income FY2021 234.18M USD. Operating income FY2022 187.83M USD. Operating income FY2023 147.18M USD. Operating income FY2024 206.37M USD. Operating income FY2025 295.25M USD. Net income FY2021 49.8M USD. Net income FY2022 −53.91M USD. Net income FY2023 −154.6M USD. Net income FY2024 −18.06M USD. Net income FY2025 190.67M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue12.91B USD11.27B USD8.83B USD7.72B USD6.7B USD
Cost of goods sold11.39B USD9.68B USD7.39B USD6.37B USD5.45B USD
Gross profit1.52B USD1.59B USD1.43B USD1.35B USD1.25B USD
Selling, general, and administrative1.22B USD1.38B USD1.29B USD1.13B USD1.01B USD
Operating expenses1.22B USD1.38B USD1.29B USD1.17B USD1.01B USD
Interest expense157.31M USD228.39M USD324.59M USD233.58M USD165.32M USD
Depreciation and amortization164.28M USD204.48M USD202.34M USD203.97M USD199.16M USD
Operating income295.25M USD206.37M USD147.18M USD187.83M USD234.18M USD
Net income190.67M USD−18.06M USD−154.6M USD−53.91M USD49.8M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

12 institutions

BTSG peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding BTSG

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Mid-Cap ETF logoiShares Core S&P Mid-Cap ETFIJH
Market value
330.35M
Weight
0.26%
AUM
125.92B USD
Expense ratio
0.05%
Price / 1D
$76.77+0.52%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
311.42M
Weight
0.01%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
248.35M
Weight
0.31%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
225.02M
Weight
0.12%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETF logoVanguard Morningstar Small-Cap Growth ETFVBK
Market value
130.12M
Weight
0.29%
AUM
43.8B USD
Expense ratio
0.05%
Price / 1D
$358.65+0.70%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
108.76M
Weight
0.11%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
90.39M
Weight
0.60%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
State Street SPDR S&P MIDCAP 400 ETF Trust logoState Street SPDR S&P MIDCAP 400 ETF TrustMDY
Market value
68.96M
Weight
0.26%
AUM
26.72B USD
Expense ratio
0.23%
Price / 1D
$699.6+0.48%

Continue in GoAI

Research BTSG

research.disclaimer